Aversion Therapy for Bacteria: Repurposing Aurodox
Aversion Therapy for Bacteria: Repurposing Aurodox
批准号:
MR/V011499/1
负责人:
Andrew Roe
金额:
$79.06万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2021
资助国家:
英国
项目状态:
未结题
起止时间:
2021 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Antibiotics have been used for many years and are central to the treatment of many common bacterial infections. However, because antibiotics kill bacteria, there is a strong selection for mutants, slightly different from the parental type of bacteria, which are not killed: a new resistant form. These resistant cases of bacteria that are no longer susceptible to common antibiotics means that there is a great need for new alternative forms of treatment. Of all the bacteria that causes problems, the gram negative family are the hardest treat because they rapidly develop resistance. One possibility is to render the disease-causing bacteria less dangerous by turning off their offensive weapons. Compounds that "turn off' bacterial weapons are called "anti-virulence" compounds because they don't try to kill the bug, they just render them less dangerous. Imagine taking an army and removing all its key weapons- it's a lot less effective. Using anti-virulence factors is attractive for the following reasons:(1) Anti-virulence compounds "disarm" bacteria rather than killing them, generating less selection for resistant mutants.(2) Secondary infections associated with antibiotic treatment such as those caused by Clostridium difficile and Candida albicans should also be dramatically reduced as natural "good" bacteria are not wiped out during treatment. (3) For toxin-producing bacteria treatment with traditional antibiotics is controversial, with some reports of increased release of toxins and more severe symptoms. By not killing the bacteria, toxin release is avoided.My lab has been developing and testing new anti-virulence compounds and working out how they function. We "re-discovered" a compound that is safe for animals, called aurodox which was actually found in the early 1970s from other bacteria that live in the soil. When we use aurodox with bacteria that cause serious diseases, specifically the infamous "burger bug" "E. coli O157" we are able to switch off the major weapon the bacteria use to attach to host cells. In effect we are just switching off the anchor used to attach to the gut, which should ensure the bacteria are simply flushed out of the body. In this work we want to show that aurodox can prevent or treat disease and also work out exactly how it works. We also want to see if aurodox has any negative effects on the "good" bacteria in our guts. Answering these questions would pave the way to use aurodox as the first treatment against EHEC and, more widely, show that anti-virulence approaches are a viable alternative to traditional antibiotics.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Optimisation of aurodox production by Streptomyces goldiniensis.
金链霉菌 Aurodox 生产的优化。
DOI:
10.1099/acmi.0.000572.v1
发表时间:
2023
期刊:
影响因子:
--
作者:
[E McHugh R]
通讯作者:
E McHugh R
DOI:
10.1128/aem.00692-22
发表时间:
2022-08-09
期刊:
Applied and environmental microbiology
影响因子:
4.4
作者:
[]
通讯作者:
D-amino acids as modulators of the genotoxic polyketide, colibactin.
-
批准号:BB/W015781/1
-
项目类别:Research Grant
-
资助金额:$61.11万
-
财政年份:2023
-
负责人:Andrew Roe
-
依托单位:
A new twist on drug design: AdhE spirosomes as cross species anti-virulence targets
-
批准号:BB/V009494/1
-
项目类别:Research Grant
-
资助金额:$63.51万
-
财政年份:2021
-
负责人:Andrew Roe
-
依托单位:
The Role of Dietary D-serine in Health and Disease
-
批准号:BB/R006539/1
-
项目类别:Research Grant
-
资助金额:$75.47万
-
财政年份:2018
-
负责人:Andrew Roe
-
依托单位:
Where and Why: The Influence of Host Metabolism on Bacterial Niche Specificity
-
批准号:BB/M029646/1
-
项目类别:Research Grant
-
资助金额:$56.07万
-
财政年份:2016
-
负责人:Andrew Roe
-
依托单位:
Utility of LOV-based Fluorescent Reporters To Monitor the Real-Time Secretion and Localisation of Bacterial Effector Proteins
-
批准号:BB/H023518/1
-
项目类别:Research Grant
-
资助金额:$12.32万
-
财政年份:2011
-
负责人:Andrew Roe
-
依托单位:
A biochemical and molecular analysis of the YhaO membrane protein in Escherichia coli O157:H7
-
批准号:BB/G011389/1
-
项目类别:Research Grant
-
资助金额:$52.3万
-
财政年份:2009
-
负责人:Andrew Roe
-
依托单位:
海外基金